A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session8a3ac2716f85468c1271a3239ef3ee4a27f8d7cf): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Covid-19 Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

img

Global Covid-19 Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Covid-19 Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Covid-19 Therapeutic market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033. Fully considering the economic change by this health crisis, Immunotherapy accounting for % of the Covid-19 Therapeutic global market in 2023, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Children segment is altered to an % CAGR throughout this forecast period.
The global key companies of Covid-19 Therapeutic include Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer and Regeneron Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
The United States Covid-19 Therapeutic market size was US$ million in 2023, while China size was US$ million. The proportion of the United States was % in 2023, while China percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period. As for the Europe Covid-19 Therapeutic landscape, Germany is projected to reach US$ million by 2033. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Covid-19 Therapeutic market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Covid-19 Therapeutic market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Covid-19 Therapeutic market. Readers of the report can become informed about current and future trends of the global Covid-19 Therapeutic market and how they will impact market growth during the forecast period.



By Company


Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Segment by Type
Immunotherapy
Life Support
Antiviral Medicine
Plasma Therapy
Others

Segment by Application


Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Covid-19 Therapeutic in global and regional level.
Chapter 3Detailed analysis of Covid-19 Therapeutic companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Immunotherapy
1.2.3 Life Support
1.2.4 Antiviral Medicine
1.2.5 Plasma Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Therapeutic Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Covid-19 Therapeutic Market Size (2018-2033)
2.2 Covid-19 Therapeutic Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global Covid-19 Therapeutic Market Size by Region (2018-2023)
2.4 Global Covid-19 Therapeutic Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 Covid-19 Therapeutic Countries Ranking by Market Size
3 Covid-19 Therapeutic Competitive by Company
3.1 Global Covid-19 Therapeutic Revenue by Players
3.1.1 Global Covid-19 Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Covid-19 Therapeutic Market Share by Players (2018-2023)
3.2 Global Covid-19 Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Covid-19 Therapeutic Revenue
3.4 Global Covid-19 Therapeutic Market Concentration Ratio
3.4.1 Global Covid-19 Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Therapeutic Revenue in 2023
3.5 Global Key Players of Covid-19 Therapeutic Head office and Area Served
3.6 Global Key Players of Covid-19 Therapeutic, Product and Application
3.7 Global Key Players of Covid-19 Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Covid-19 Therapeutic Breakdown Data by Type
4.1 Global Covid-19 Therapeutic Historic Revenue by Type (2018-2023)
4.2 Global Covid-19 Therapeutic Forecasted Revenue by Type (2024-2033)
5 Global Covid-19 Therapeutic Breakdown Data by Application
5.1 Global Covid-19 Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Covid-19 Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Covid-19 Therapeutic Revenue by Company (2021-2023)
6.2 North America Covid-19 Therapeutic Revenue by Type (2018-2033)
6.3 North America Covid-19 Therapeutic Revenue by Application (2018-2033)
6.4 North America Covid-19 Therapeutic Revenue by Country (2018-2033)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Covid-19 Therapeutic Revenue by Company (2021-2023)
7.2 Europe Covid-19 Therapeutic Revenue by Type (2018-2033)
7.3 Europe Covid-19 Therapeutic Revenue by Application (2018-2033)
7.4 Europe Covid-19 Therapeutic Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Covid-19 Therapeutic Revenue by Company (2021-2023)
8.2 Asia Pacific Covid-19 Therapeutic Revenue by Type (2018-2033)
8.3 Asia Pacific Covid-19 Therapeutic Revenue by Application (2018-2033)
8.4 Asia Pacific Covid-19 Therapeutic Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Covid-19 Therapeutic Revenue by Company (2021-2023)
9.2 Latin America Covid-19 Therapeutic Revenue by Type (2018-2033)
9.3 Latin America Covid-19 Therapeutic Revenue by Application (2018-2033)
9.4 Latin America Covid-19 Therapeutic Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Covid-19 Therapeutic Revenue by Company (2021-2023)
10.2 Middle East and Africa Covid-19 Therapeutic Revenue by Type (2018-2033)
10.3 Middle East and Africa Covid-19 Therapeutic Revenue by Application (2018-2033)
10.4 Middle East and Africa Covid-19 Therapeutic Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Company Details
11.1.2 Cadila Healthcare Business Overview
11.1.3 Cadila Healthcare Covid-19 Therapeutic Products and Services
11.1.4 Cadila Healthcare Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.1.5 Cadila Healthcare Covid-19 Therapeutic SWOT Analysis
11.1.6 Cadila Healthcare Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Covid-19 Therapeutic Products and Services
11.2.4 Johnson & Johnson Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.2.5 Johnson & Johnson Covid-19 Therapeutic SWOT Analysis
11.2.6 Johnson & Johnson Recent Development
11.3 ImmunoPrecise
11.3.1 ImmunoPrecise Company Details
11.3.2 ImmunoPrecise Business Overview
11.3.3 ImmunoPrecise Covid-19 Therapeutic Products and Services
11.3.4 ImmunoPrecise Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.3.5 ImmunoPrecise Covid-19 Therapeutic SWOT Analysis
11.3.6 ImmunoPrecise Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Covid-19 Therapeutic Products and Services
11.4.4 Novartis Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.4.5 Novartis Covid-19 Therapeutic SWOT Analysis
11.4.6 Novartis Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Covid-19 Therapeutic Products and Services
11.5.4 AstraZeneca Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.5.5 AstraZeneca Covid-19 Therapeutic SWOT Analysis
11.5.6 AstraZeneca Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Covid-19 Therapeutic Products and Services
11.6.4 Cipla Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.6.5 Cipla Covid-19 Therapeutic SWOT Analysis
11.6.6 Cipla Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Covid-19 Therapeutic Products and Services
11.7.4 AbbVie Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.7.5 AbbVie Covid-19 Therapeutic SWOT Analysis
11.7.6 AbbVie Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Covid-19 Therapeutic Products and Services
11.8.4 Bayer Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.8.5 Bayer Covid-19 Therapeutic SWOT Analysis
11.8.6 Bayer Recent Development
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Products and Services
11.9.4 Regeneron Pharmaceuticals Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.9.5 Regeneron Pharmaceuticals Covid-19 Therapeutic SWOT Analysis
11.9.6 Regeneron Pharmaceuticals Recent Development
11.10 Ascletis Pharma
11.10.1 Ascletis Pharma Company Details
11.10.2 Ascletis Pharma Business Overview
11.10.3 Ascletis Pharma Covid-19 Therapeutic Products and Services
11.10.4 Ascletis Pharma Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.10.5 Ascletis Pharma Covid-19 Therapeutic SWOT Analysis
11.10.6 Ascletis Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Covid-19 Therapeutic Products and Services
11.11.4 GlaxoSmithKline Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Development
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Details
11.12.2 Gilead Sciences Business Overview
11.12.3 Gilead Sciences Covid-19 Therapeutic Products and Services
11.12.4 Gilead Sciences Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.12.5 Gilead Sciences Recent Development
11.13 Pharmstandard
11.13.1 Pharmstandard Company Details
11.13.2 Pharmstandard Business Overview
11.13.3 Pharmstandard Covid-19 Therapeutic Products and Services
11.13.4 Pharmstandard Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.13.5 Pharmstandard Recent Development
11.14 Fujifilm Holdings
11.14.1 Fujifilm Holdings Company Details
11.14.2 Fujifilm Holdings Business Overview
11.14.3 Fujifilm Holdings Covid-19 Therapeutic Products and Services
11.14.4 Fujifilm Holdings Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.14.5 Fujifilm Holdings Recent Development
11.15 Zhejiang Hisun Pharmaceutical Co. Ltd
11.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
11.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
11.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Products and Services
11.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
11.16 Roche
11.16.1 Roche Company Details
11.16.2 Roche Business Overview
11.16.3 Roche Covid-19 Therapeutic Products and Services
11.16.4 Roche Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.16.5 Roche Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Covid-19 Therapeutic Products and Services
11.17.4 Sanofi Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.17.5 Sanofi Recent Development
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Covid-19 Therapeutic Products and Services
11.18.4 Pfizer Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023)
11.18.5 Pfizer Recent Development
12 Covid-19 Therapeutic Market Dynamics
12.1 Covid-19 Therapeutic Industry Trends
12.2 Covid-19 Therapeutic Market Drivers
12.3 Covid-19 Therapeutic Market Challenges
12.4 Covid-19 Therapeutic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Covid-19 Therapeutic Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Life Support
Table 4. Key Players of Antiviral Medicine
Table 5. Key Players of Plasma Therapy
Table 6. Key Players of Others
Table 7. Global Covid-19 Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 8. Global Covid-19 Therapeutic Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 9. Global Covid-19 Therapeutic Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Covid-19 Therapeutic Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 11. Global Covid-19 Therapeutic Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 12. Global Covid-19 Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Covid-19 Therapeutic Market Share by Players (2018-2023)
Table 14. Global Top Covid-19 Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Therapeutic as of 2023)
Table 15. Ranking of Global Top Covid-19 Therapeutic Companies by Revenue (US$ Million) in 2023
Table 16. Global 5 Largest Players Market Share by Covid-19 Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 17. Global Key Players of Covid-19 Therapeutic, Headquarters and Area Served
Table 18. Global Key Players of Covid-19 Therapeutic, Product and Application
Table 19. Global Key Players of Covid-19 Therapeutic, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global Covid-19 Therapeutic Revenue Market Share by Type (2018-2023)
Table 23. Global Covid-19 Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 24. Global Covid-19 Therapeutic Revenue Market Share by Type (2024-2033)
Table 25. Global Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global Covid-19 Therapeutic Revenue Market Share by Application (2018-2023)
Table 27. Global Covid-19 Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 28. Global Covid-19 Therapeutic Revenue Market Share by Application (2024-2033)
Table 29. North America Covid-19 Therapeutic Revenue by Company (2021-2023) & (US$ Million)
Table 30. North America Covid-19 Therapeutic Revenue by Type (2018-2023) & (US$ Million)
Table 31. North America Covid-19 Therapeutic Revenue by Type (2024-2033) & (US$ Million)
Table 32. North America Covid-19 Therapeutic Revenue by Application (2018-2023) & (US$ Million)
Table 33. North America Covid-19 Therapeutic Revenue by Application (2024-2033) & (US$ Million)
Table 34. North America Covid-19 Therapeutic Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 35. North America Covid-19 Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 36. North America Covid-19 Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 37. Europe Covid-19 Therapeutic Revenue by Company (2021-2023) & (US$ Million)
Table 38. Europe Covid-19 Therapeutic Revenue by Type (2018-2023) & (US$ Million)
Table 39. Europe Covid-19 Therapeutic Revenue by Type (2024-2033) & (US$ Million)
Table 40. Europe Covid-19 Therapeutic Revenue by Application (2018-2023) & (US$ Million)
Table 41. Europe Covid-19 Therapeutic Revenue by Application (2024-2033) & (US$ Million)
Table 42. Europe Covid-19 Therapeutic Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 43. Europe Covid-19 Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 44. Europe Covid-19 Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 45. Asia Pacific Covid-19 Therapeutic Revenue by Company (2021-2023) & (US$ Million)
Table 46. Asia Pacific Covid-19 Therapeutic Revenue by Type (2018-2023) & (US$ Million)
Table 47. Asia Pacific Covid-19 Therapeutic Revenue by Type (2024-2033) & (US$ Million)
Table 48. Asia Pacific Covid-19 Therapeutic Revenue by Application (2018-2023) & (US$ Million)
Table 49. Asia Pacific Covid-19 Therapeutic Revenue by Application (2024-2033) & (US$ Million)
Table 50. Asia-Pacific Covid-19 Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 51. Asia Pacific Covid-19 Therapeutic Revenue by Region (2018-2023) & (US$ Million)
Table 52. Asia Pacific Covid-19 Therapeutic Revenue by Region (2024-2033) & (US$ Million)
Table 53. Latin America Covid-19 Therapeutic Revenue by Company (2021-2023) & (US$ Million)
Table 54. Latin America Covid-19 Therapeutic Revenue by Type (2018-2023) & (US$ Million)
Table 55. Latin America Covid-19 Therapeutic Revenue by Type (2024-2033) & (US$ Million)
Table 56. Latin America Covid-19 Therapeutic Revenue by Application (2018-2023) & (US$ Million)
Table 57. Latin America Covid-19 Therapeutic Revenue by Application (2024-2033) & (US$ Million)
Table 58. Latin America Covid-19 Therapeutic Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 59. Latin America Covid-19 Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 60. Latin America Covid-19 Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 61. Middle East and Africa Covid-19 Therapeutic Revenue by Company (2021-2023) & (US$ Million)
Table 62. Middle East and Africa Covid-19 Therapeutic Revenue by Type (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Covid-19 Therapeutic Revenue by Type (2024-2033) & (US$ Million)
Table 64. Middle East and Africa Covid-19 Therapeutic Revenue by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Covid-19 Therapeutic Revenue by Application (2024-2033) & (US$ Million)
Table 66. Middle East and Africa Covid-19 Therapeutic Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 67. Middle East and Africa Covid-19 Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 68. Middle East and Africa Covid-19 Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 69. Cadila Healthcare Company Details
Table 70. Cadila Healthcare Business Overview
Table 71. Cadila Healthcare Covid-19 Therapeutic Product and Services
Table 72. Cadila Healthcare Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 73. Cadila Healthcare Covid-19 Therapeutic SWOT Analysis
Table 74. Cadila Healthcare Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Covid-19 Therapeutic Product and Services
Table 78. Johnson & Johnson Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 79. Johnson & Johnson Covid-19 Therapeutic SWOT Analysis
Table 80. Johnson & Johnson Recent Development
Table 81. ImmunoPrecise Company Details
Table 82. ImmunoPrecise Business Overview
Table 83. ImmunoPrecise Covid-19 Therapeutic Product and Services
Table 84. ImmunoPrecise Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 85. ImmunoPrecise Covid-19 Therapeutic SWOT Analysis
Table 86. ImmunoPrecise Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Covid-19 Therapeutic Product and Services
Table 90. Novartis Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 91. Novartis Covid-19 Therapeutic SWOT Analysis
Table 92. Novartis Recent Development
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Covid-19 Therapeutic Product and Services
Table 96. AstraZeneca Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 97. AstraZeneca Covid-19 Therapeutic SWOT Analysis
Table 98. AstraZeneca Recent Development
Table 99. Cipla Company Details
Table 100. Cipla Business Overview
Table 101. Cipla Covid-19 Therapeutic Product and Services
Table 102. Cipla Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 103. Cipla Covid-19 Therapeutic SWOT Analysis
Table 104. Cipla Recent Development
Table 105. AbbVie Company Details
Table 106. AbbVie Business Overview
Table 107. AbbVie Covid-19 Therapeutic Product and Services
Table 108. AbbVie Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 109. AbbVie Covid-19 Therapeutic SWOT Analysis
Table 110. AbbVie Recent Development
Table 111. Bayer Company Details
Table 112. Bayer Business Overview
Table 113. Bayer Covid-19 Therapeutic Product and Services
Table 114. Bayer Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 115. Bayer Covid-19 Therapeutic SWOT Analysis
Table 116. Bayer Recent Development
Table 117. Regeneron Pharmaceuticals Company Details
Table 118. Regeneron Pharmaceuticals Business Overview
Table 119. Regeneron Pharmaceuticals Covid-19 Therapeutic Product and Services
Table 120. Regeneron Pharmaceuticals Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 121. Regeneron Pharmaceuticals Covid-19 Therapeutic SWOT Analysis
Table 122. Regeneron Pharmaceuticals Recent Development
Table 123. Ascletis Pharma Company Details
Table 124. Ascletis Pharma Business Overview
Table 125. Ascletis Pharma Covid-19 Therapeutic Product and Services
Table 126. Ascletis Pharma Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 127. Ascletis Pharma Covid-19 Therapeutic SWOT Analysis
Table 128. Ascletis Pharma Recent Development
Table 129. GlaxoSmithKline Company Details
Table 130. GlaxoSmithKline Business Overview
Table 131. GlaxoSmithKline Covid-19 Therapeutic Product and Services
Table 132. GlaxoSmithKline Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 133. GlaxoSmithKline Recent Development
Table 134. Gilead Sciences Company Details
Table 135. Gilead Sciences Business Overview
Table 136. Gilead Sciences Covid-19 Therapeutic Product and Services
Table 137. Gilead Sciences Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 138. Gilead Sciences Recent Development
Table 139. Pharmstandard Company Details
Table 140. Pharmstandard Business Overview
Table 141. Pharmstandard Covid-19 Therapeutic Product and Services
Table 142. Pharmstandard Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 143. Pharmstandard Recent Development
Table 144. Fujifilm Holdings Company Details
Table 145. Fujifilm Holdings Business Overview
Table 146. Fujifilm Holdings Covid-19 Therapeutic Product and Services
Table 147. Fujifilm Holdings Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 148. Fujifilm Holdings Recent Development
Table 149. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
Table 150. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
Table 151. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product and Services
Table 152. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 153. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
Table 154. Roche Company Details
Table 155. Roche Business Overview
Table 156. Roche Covid-19 Therapeutic Product and Services
Table 157. Roche Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 158. Roche Recent Development
Table 159. Sanofi Company Details
Table 160. Sanofi Business Overview
Table 161. Sanofi Covid-19 Therapeutic Product and Services
Table 162. Sanofi Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 163. Sanofi Recent Development
Table 164. Pfizer Company Details
Table 165. Pfizer Business Overview
Table 166. Pfizer Covid-19 Therapeutic Product and Services
Table 167. Pfizer Covid-19 Therapeutic Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 168. Pfizer Recent Development
Table 169. Covid-19 Therapeutic Market Trends
Table 170. Covid-19 Therapeutic Market Drivers
Table 171. Covid-19 Therapeutic Market Challenges
Table 172. Covid-19 Therapeutic Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Therapeutic Product Picture
Figure 2. Global Covid-19 Therapeutic Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global Covid-19 Therapeutic Market Share by Type: 2023 VS 2033
Figure 4. Immunotherapy Features
Figure 5. Life Support Features
Figure 6. Antiviral Medicine Features
Figure 7. Plasma Therapy Features
Figure 8. Others Features
Figure 9. Global Covid-19 Therapeutic Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 10. Global Covid-19 Therapeutic Market Share by Application: 2023 VS 2033
Figure 11. Children
Figure 12. Adult
Figure 13. Covid-19 Therapeutic Report Years Considered
Figure 14. Global Covid-19 Therapeutic Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 15. Global Covid-19 Therapeutic Market Size 2018-2033 (US$ Million)
Figure 16. Global Covid-19 Therapeutic Market Size Market Share by Region: 2023 VS 2033
Figure 17. Global Covid-19 Therapeutic Revenue Market Share by Region in 2018 VS 2023
Figure 18. Global Covid-19 Therapeutic Revenue Market Share Forecast by Region (2024-2033)
Figure 19. Global Top 10 Covid-19 Therapeutic Countries Ranking by Market Size (US$ Million) in 2023
Figure 20. Global Covid-19 Therapeutic Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 21. Global Covid-19 Therapeutic Market Share by Players in 2023
Figure 22. Global Top Covid-19 Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Therapeutic as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Covid-19 Therapeutic Revenue in 2023
Figure 24. North America Covid-19 Therapeutic Revenue Market Share by Company in 2023
Figure 25. North America Covid-19 Therapeutic Revenue Market Share by Type (2018-2033)
Figure 26. North America Covid-19 Therapeutic Revenue Market Share by Application (2018-2033)
Figure 27. North America Covid-19 Therapeutic Revenue Share by Country (2018-2033)
Figure 28. United States Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 29. Canada Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 30. Europe Covid-19 Therapeutic Revenue Market Share by Company in 2023
Figure 31. Europe Covid-19 Therapeutic Revenue Market Share by Type (2018-2033)
Figure 32. Europe Covid-19 Therapeutic Revenue Market Share by Application (2018-2033)
Figure 33. Europe Covid-19 Therapeutic Revenue Share by Country (2018-2033)
Figure 34. Germany Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 35. France Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 36. U.K. Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 37. Italy Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 38. Russia Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 39. Asia Pacific Covid-19 Therapeutic Revenue Market Share by Company in 2023
Figure 40. Asia Pacific Covid-19 Therapeutic Revenue Market Share by Type (2018-2033)
Figure 41. Asia Pacific Covid-19 Therapeutic Revenue Market Share by Application (2018-2033)
Figure 42. Asia Pacific Covid-19 Therapeutic Revenue Share by Region (2018-2033)
Figure 43. China Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 44. Japan Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 45. South Korea Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 46. India Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 47. Australia Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 48. China Taiwan Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 49. Indonesia Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 50. Thailand Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 51. Malaysia Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 52. Latin America Covid-19 Therapeutic Revenue Market Share by Company in 2023
Figure 53. Latin America Covid-19 Therapeutic Revenue Market Share by Type (2018-2033)
Figure 54. Latin America Covid-19 Therapeutic Revenue Market Share by Application (2018-2033)
Figure 55. Latin America Covid-19 Therapeutic Revenue Share by Country (2018-2033)
Figure 56. Mexico Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 57. Brazil Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 58. Argentina Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 59. Middle East and Africa Covid-19 Therapeutic Revenue Market Share by Company in 2023
Figure 60. Middle East and Africa Covid-19 Therapeutic Revenue Market Share by Type (2018-2033)
Figure 61. Middle East and Africa Covid-19 Therapeutic Revenue Market Share by Application (2018-2033)
Figure 62. Middle East and Africa Covid-19 Therapeutic Revenue Share by Country (2018-2033)
Figure 63. Turkey Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 64. Saudi Arabia Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 65. UAE Covid-19 Therapeutic Revenue (2018-2033) & (US$ Million)
Figure 66. Cadila Healthcare Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 67. Johnson & Johnson Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 68. ImmunoPrecise Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 69. Novartis Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 70. AstraZeneca Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 71. Cipla Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 72. AbbVie Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 73. Bayer Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 74. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 75. Ascletis Pharma Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 76. GlaxoSmithKline Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 77. Gilead Sciences Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 78. Pharmstandard Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 79. Fujifilm Holdings Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 80. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 81. Roche Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 82. Sanofi Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 83. Pfizer Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed